Search
for
Sort by
Research 331–360 of 1000+
- 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Advance Understanding and New Treatment of Alopecia Areata
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients.
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Immune therapies for alopecia areata: evidence and new perspectives
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Exploring novel management options for alopecia areata
- Alopecia Areata: Pathogenesis, current treatments, and future perspectives
- Review of efficacy of baricitinib in the treatment of alopecia areata
- Alopecia areata: medical treatments
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Alopecia areata – Current understanding and management
- Janus kinase inhibitors for alopecia areata: A narrative review
- Is female-pattern hair loss an autoimmune-like disorder? Unveiling the “silent” inflammation
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- Pathomechanisms of immune-mediated alopecia
- The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review
- Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- A review of Janus kinase inhibitor use in scarring alopecia
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Hair regrowth in a patient with central centrifugal cicatricial alopecia after a 2-month trial of baricitinib
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Baricitinib: A Review in Severe Alopecia Areata
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- SYSTEMATIC REVIEW OF ORAL JANUS KINASE INHIBITORS IN ALOPECIA AREATA: INSIGHTS FROM 2020 TO 2025 STUDIES
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Intrinsic Modulators of Hair Growth: Roles of Growth Factors, Cytokines, Chemokines, and Interferons